PREVYMIS 240 mg/1

Prevymis 240 mg is an antiviral medication used to prevent cytomegalovirus (CMV) infection in adults. This film-coated tablet is designed for oral administration and is commonly prescribed for post-transplant patients.

Prevymis 240 mg is primarily used to prevent CMV infection in adults who have received a stem cell transplant. This medication is often prescribed to reduce the risk of CMV reactivation, which can be particularly concerning for individuals with weakened immune systems. Patients may wonder, 'What is Prevymis used for?' and the answer lies in its role as a prophylactic treatment against CMV, a common virus that can cause serious complications in immunocompromised individuals.

Common effects of Prevymis 240 mg may include gastrointestinal issues such as nausea, vomiting, and diarrhea. Some users might also experience fatigue or headache. These effects are generally mild and temporary, but it's important to monitor any persistent or severe symptoms.

Prevymis 240 mg should be handled with care, especially by individuals with known allergies to letermovir or any of its components. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should also be aware of potential interactions with other medications and inform their healthcare provider of all current treatments.

Prevymis 240 mg may interact with certain medications, particularly those metabolized by the liver enzyme CYP3A. This includes drugs like cyclosporine, which is often used in transplant patients. Additionally, patients should avoid consuming grapefruit or grapefruit juice, as it can affect the metabolism of Prevymis and potentially increase the risk of side effects.